Skip to content

Clinical trials

Lymphoma trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Country / region: Singapore Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20103
20111
20122
20141
20164
20173
20182
20201
20211
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting3
Unknown status3
Terminated2
Recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
National Cancer Centre, Singapore2
Novartis Pharmaceuticals2
Pfizer2
Singapore General Hospital2
Bayer1
Celgene1
Gamida Cell ltd1
Janssen Research & Development, LLC1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma22
Lymphoma, Non-Hodgkin4
Lymphoma, Large B-Cell, Diffuse3
Hematologic Neoplasms2
Lymphoma, B-Cell2
Lymphoma, Large-Cell, Anaplastic2
Myelodysplastic Syndromes2
Sarcoma2
Amyloidosis1
Breast Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.